Biogen Idec Inc (NASDAQ:BIIB)

During the Trading Day
291.48 +5.99 / +2.10%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
291.48 0.00 / 0.00%
Volume: 39.0K
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data -...
10:47am /
Market Wrap For April 10: Wednesday's Rally Completely Forgotten
Apr 10 / Benzinga
3 Biotech Opportunities Following This Selloff
9:31am /
Is the robust IPO market affecting the broader indices?
Apr 10 /
'Fast Money' Recap: Impressed by Yahoo!
5:06am /
Stock Market News for April 10, 2014 - Market News
Apr 10 /
Health Care Stocks: Check Out This Low-Cost Market Beater
Apr 15 /
Code red: Stocks tank on Wall Street
Apr 10 /
Biotech Bubble Bust: 2 Ways to Win
Apr 15 /
3 Top-Ranked Biotech Stocks on the Rebound - Analyst Blog
Apr 10 /
Will Abbott Labs (ABT) Disappoint This Quarter? - Analyst Blog
Apr 15 /
Fitz Bits: The Biotech Wreck
Apr 09 /
Are Biotechs Bad Medicine for the S&P 500?
Apr 15 /
Why Gilead Sciences, AbbVie Inc., and Biogen Idec Are Today's 3 Worst Stocks
Apr 08 /
3 Stocks Reiterated As A Buy: COP, OXY, BIIB
Apr 14 /
Tweet of the Week: Big Biotech Dominates Industry Gains
Apr 07 /
Gilead Bucks Biotech Trend Thanks to Sovaldi News - Analyst Blog
Apr 14 /
Does Biogen Idec Inc Have a New Blockbuster Hemophilia Therapy?
Apr 07 /
A Blueprint for Highflier Stability
Apr 14 /
Momentum Slide to Continue for Netflix, Facebook? - Analyst Blog
Apr 07 /
Stock Market News for April 14, 2014 - Market News
Apr 14 /
Stock Market News for April 07, 2014 - Market News
Apr 07 /
Will Johnson & Johnson (JNJ) Miss This Earnings Season? - Analyst Blog
Apr 14 /
Stock Market News for April 04, 2014 - Market News
Apr 04 /
Stocks bounce back...somewhat
Apr 14 /
Stocks: brutal finale to week
Apr 04 /
Biogen to Present Clinical Data from Neurology Portfolio at AAN Annual Meeting
Apr 14 / Benzinga
Drugmakers Build to Buy
Apr 03 /
Why Biogen Idec Inc., Vertex Pharmaceuticals Incorporated, and Broadcom Corp. Are Tod...
Apr 11 /
Will Biogen Idec Inc. Rule Biotech in 2014?
Apr 03 /
Eight pricey stocks haunting the Nasdaq
Apr 11 / Fortune
Biotech Stock Roundup: Biogen Drug Approved, Exelixis Tumbles on Study Update - Analy...
Apr 02 /
Positive Data on Biogen/Sobi's Eloctate - Analyst Blog
Apr 11 /
Bristol-Myers Squibb: side effects
Apr 01 /
Stock Market News for April 11, 2014 - Market News
Apr 11 /
Baxter: own devices
Mar 27 /
Tech stock rout continues in Asia
Apr 11 /
Biotech sell-off tests nerves
Mar 24 /

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.